TickerFacts.

Solventum Corp (SOLV): EPS (Diluted)

Annual figures by period end, from SEC filings.

$8.88
Year ended 2025-12-31
+4.5%
3-year compound annual growth
2022-12-31: $7.782023-12-31: $7.792024-12-31: $2.762025-12-31: $8.88$8.88
2022-12-31 EPS (Diluted) (USD per share) 2025-12-31
Period endedEPS (Diluted)Change YoYSource filing
2025-12-31$8.88+221.7%2026-02-27, From 2025-01-01
2024-12-31$2.76-64.6%2026-02-27, From 2024-01-01
2023-12-31$7.79+0.1%2026-02-27, From 2023-01-01
2022-12-31$7.78n/a2025-02-28, From 2022-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Solventum Corp (SOLV)2025-12-31$8.88+221.7%
Baxter International Inc (BAX)2025-12-31-$1.87n/m
ResMed Inc (RMD)2026-06-30$10.43+9.7%
Dexcom Inc (DXCM)2025-12-31$2.09+47.2%
Boston Scientific Corp (BSX)2025-12-31$1.94+55.2%
Becton Dickinson & Co (BDX)2025-09-30$5.82-0.7%
MiniMed Group, Inc. (MMED)2026-04-24-$1.30n/m
West Pharmaceutical Services Inc (WST)2025-12-31$6.79+1.5%
Globus Medical Inc (GMED)2025-12-31$3.92+422.7%

Compare SOLV, BAX, RMD, DXCM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗